Literature DB >> 10742986

Vitamin B12 transporters.

G J Russell-Jones1, D H Alpers.   

Abstract

The uptake of vitamin B12 from the intestine into the circulation is perhaps the most complex uptake mechanism of all the vitamins, involving no less than five separate VB12-binding molecules, receptors and transporters. Each molecule involved in uptake has a separate affinity and specificity for VB12 as well as a separate cell receptor. Thus VB12 is initially bound by haptocorrin in the stomach, then by IF in the small intestine. An IF receptor is then involved in uptake of the IF-VB12 complex by the intestinal epithelial cell, with the subsequent proteolytic release of VB12 and subsequent binding to TcII. The TcII receptor then transports the TcII-VB12 complex across the cell, whence it is released into the circulation. It is surprising, then, that despite its complexity, it has been possible to harness the vitamin VB12 uptake mechanism to enhance the oral uptake of peptides, proteins, and nanoparticles.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10742986     DOI: 10.1007/0-306-46812-3_17

Source DB:  PubMed          Journal:  Pharm Biotechnol        ISSN: 1078-0467


  5 in total

Review 1.  Biochemistry, function, and deficiency of vitamin B12 in Caenorhabditis elegans.

Authors:  Tomohiro Bito; Fumio Watanabe
Journal:  Exp Biol Med (Maywood)       Date:  2016-08-02

Review 2.  Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins' Synthesis in Solid Cancers.

Authors:  Valentin Lacombe; Guy Lenaers; Geoffrey Urbanski
Journal:  Nutrients       Date:  2022-05-14       Impact factor: 6.706

3.  Evaluation of bioadhesive capacity and immunoadjuvant properties of vitamin B(12)-Gantrez nanoparticles.

Authors:  Hesham H Salman; Carlos Gamazo; P Chris de Smidt; Gregory Russell-Jones; Juan M Irache
Journal:  Pharm Res       Date:  2008-08-05       Impact factor: 4.200

Review 4.  Absorption and blood/cellular transport of folate and cobalamin: Pharmacokinetic and physiological considerations.

Authors:  David H Alpers
Journal:  Biochimie       Date:  2015-11-14       Impact factor: 4.079

Review 5.  Glucagon-like peptide-1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting?

Authors:  Tito Borner; Ian C Tinsley; Robert P Doyle; Matthew R Hayes; Bart C De Jonghe
Journal:  Br J Pharmacol       Date:  2021-09-14       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.